Sam Hong
Affiliations: | 2015 | Rapafusyn Pharmaceuticals |
Google:
"Sam Hong"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Wang Y, Peng H, Guo Z, et al. (2021) Influence of stereochemistry on the activity of rapadocin, an isoform-specific inhibitor of the nucleoside transporter ENT1. Chemical Science. 12: 11484-11489 |
| Liu JO, Guo Z, Cheng Z, et al. (2019) Discovery of a potent GLUT inhibitor using rapafucin 3D microarrays. Angewandte Chemie (International Ed. in English) |
| Guo Z, Hong SY, Wang J, et al. (2018) Rapamycin-inspired macrocycles with new target specificity. Nature Chemistry |
| Head SA, Shi WQ, Yang EJ, et al. (2017) Simultaneous Targeting of NPC1 and VDAC1 by Itraconazole Leads to Synergistic Inhibition of mTOR Signaling and Angiogenesis. Acs Chemical Biology. 12: 174-182 |
| Maciag AE, Nandurdikar RS, Hong SY, et al. (2011) Activation of the c-Jun N-terminal kinase/activating transcription factor 3 (ATF3) pathway characterizes effective arylated diazeniumdiolate-based nitric oxide-releasing anticancer prodrugs. Journal of Medicinal Chemistry. 54: 7751-8 |